Results 121 to 130 of about 178,280 (162)

Pediatric Ocular Myasthenia Gravis

Current Treatment Options in Neurology, 2019
We present a review of current strategies in the treatment of pediatric ocular myasthenia gravis (OMG). A critical appraisal was performed of the current literature available on OMG and the treatment options available for all age populations. From this data, we present the evidence surrounding therapeutic options for pediatric OMG and discuss treatment
Kristen, Fisher, Veeral, Shah
openaire   +2 more sources

Myasthenia gravis: Antibodies to acetylcholine receptor in ocular myasthenia gravis

Journal of Neurology, 1981
To improve the sensitivity of the radioimmunoassay method for anti-AChR-antibody, large amounts of sera from patients with myasthenia gravis, and higher concentrations of antigens and rabbit anti-human-IgG-antiserum, were used. These procedures enabled measurement of the titre value of over 0.04 pmol/ml serum and this value revealed a sensitivity about
K, Oda, Y, Ito
openaire   +2 more sources

Ocular myasthenia gravis

Current Opinion in Ophthalmology, 1996
Ocular myasthenia gravis may mimic any pupil-spared, painless, nonproptotic ophthalmoplegia with or without ptosis. This review references recent papers regarding clinical features, diagnostic techniques, and treatment for ocular myasthenia gravis.
openaire   +2 more sources

Ocular myasthenia gravis

Current Opinion in Ophthalmology, 2018
Myasthenia gravis is an autoimmune disease that commonly affects the palpebral and extraocular muscles. Ocular myasthenia gravis (OMG) is a variant of the disease that is confined to the ocular muscles but frequently becomes generalized over time.
Elizabeth, Fortin, Dean M, Cestari, David H, Weinberg   +2 more
openaire   +2 more sources

SFEMG in ocular myasthenia gravis diagnosis

Clinical Neurophysiology, 2000
In typical cases, the patient's history and clinical examination make it possible to diagnose ocular myasthenia gravis (OMG). But, in many cases a clear clinical picture is not present and OMG diagnosis is very difficult because gold diagnostic standard tests are not available.
Luca Padua, Pietro Tonali, P Tonali
exaly   +3 more sources

Penicillamine-Induced Ocular Myasthenia Gravis

American Journal of Ophthalmology, 1985
Two patients with rheumatoid arthritis (two women, 58 and 62 years old) developed reversible penicillamine-induced ocular myasthenia gravis. Both had the HLA-DR1 antigen, unlike most patients with idiopathic myasthenia gravis who show HLA-DR3, suggesting that penicillamine-induced myasthenia gravis and its idiopathic counterpart occur in patients with ...
M, O'Keefe, K D, Morley, W M, Haining, A, Smith   +3 more
openaire   +2 more sources

Ocular Myasthenia Gravis

Archives of Neurology, 1997
In their discussion of the results of a retrospective chart review of 32 patients with ocular myasthenia gravis treated with prednisone for variable periods, Kupersmith and colleagues 1 neglected to mention the only controlled clinical trial of anything in myasthenia—namely, of corticotropin.
openaire   +1 more source

Strabismus Surgery in Ocular Myasthenia gravis

Ophthalmologica, 2010
We evaluated the efficacy of eye muscle surgery in 4 patients with ocular myasthenia gravis with troublesome diplopia. All patients were in remission and had shown a consistently stable angle of deviation for at least 6 months preoperatively. The extent of eye muscle surgery was based on the degree of deviation in the primary position, and conventional
H, Ohtsuki, S, Hasebe, M, Okano, T, Furuse   +3 more
openaire   +2 more sources

Immunotherapy of Ocular Myasthenia Gravis Reduces Conversion to Generalized Myasthenia Gravis

Journal of Neuro-Ophthalmology, 2003
Several retrospective studies have suggested that immunotherapy, including prednisolone, azathioprine and thymectomy, reduces progression of ocular myasthenia gravis to generalized myasthenia gravis. This study examines the effect of immunotherapy on generalization rates in ocular myasthenia patients who are acetylcholine receptor (AChR) antibody ...
Jared, Mee, Mark, Paine, Edward, Byrne, John, King, Katrina, Reardon, Justin, O'Day   +5 more
openaire   +2 more sources

Ocular Myasthenia Gravis and Hashimoto's Thyroiditis

American Journal of Ophthalmology, 1975
Two patients had ocular myasthenia gravis coexistent with Hashimoto's thyroiditis. A 37-year-old woman presented with diplopia and displayed a head tremor and thyroid enlargement. Thyroid function tests showed an elevated thyroid stimulating hormone (TSH).
R H, Osher, J L, Smith
openaire   +2 more sources